Science & Enterprise subscription

Follow us on Twitter

  • The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with… https://t.co/kXBqtTLwqp
    about 7 mins ago
  • New post on Science and Enterprise: Infographic – Major Cities Far Short of Herd Immunity https://t.co/ijj1IqTb6V #Science #Business
    about 10 mins ago
  • An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later ho… https://t.co/TupWwuG3ok
    about 18 hours ago
  • New post on Science and Enterprise: Home-Based Cancer Care Boosts Outcomes, Cuts Costs https://t.co/9zcrG432As #Science #Business
    about 18 hours ago
  • Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19...… https://t.co/nUXjHixhfe
    about 19 hours ago

Please share Science & Enterprise

Infographic – Major Cities Far Short of Herd Immunity

Herd immunity chart

The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with antibodies against the coronavirus. . . . → Read More: Infographic – Major Cities Far Short of Herd Immunity

Home-Based Cancer Care Boosts Outcomes, Cuts Costs

Stethoscope and iPhone

An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later hospital visits and lowers overall patient costs. . . . → Read More: Home-Based Cancer Care Boosts Outcomes, Cuts Costs

NIH Funds Light-Aided Gene Therapy for Eye Disease

Eye measurements

A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received an NIH grant to advance its technology. . . . → Read More: NIH Funds Light-Aided Gene Therapy for Eye Disease

Drug Added to Covid-19 Lung Disease Trial

lung illustration

A clinical trial evaluating numerous therapies for a serious lung complication of Covid-19 infections is adding a drug to treat glaucoma to the study. . . . → Read More: Drug Added to Covid-19 Lung Disease Trial

Drug Maker Licenses Low-Dose Vaccine Patch

Nanopatch system

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

Health Research Commercialization Company Launched

Microscope

University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market. . . . → Read More: Health Research Commercialization Company Launched

Antibody Drug Biotech Raises $105M in Venture Funds

Human B-cell

A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds

Labs Creating Mask Electronic Sterilization Process

N95 respirator mask

Researchers from academic engineering and biology labs designed an electronic process for sterilizing N95 respirator face masks enabling their safe reuse. . . . → Read More: Labs Creating Mask Electronic Sterilization Process

Merck Inks Three Covid-19 Vaccine, Therapy Deals

SARS-Cov-2 virus

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

Depression Therapy Licensed for Online Distribution

Man with depression

A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use. . . . → Read More: Depression Therapy Licensed for Online Distribution